Unexpected outcomes of CDK4/6 inhibition

Oncotarget

Volumn 4, Issue 2, 2013, Pages 176-177

  Choi, Yoon Jong ^a   Sicinski, Piotr ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; NOTCH1 RECEPTOR; PROTEIN KINASE B;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; BREAST CANCER; CANCER INHIBITION; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL AGING; CYCLIN D1 GENE; CYCLIN D2 GENE; CYTOSTASIS; EDITORIAL; GENE ACTIVATION; GENE INACTIVATION; GENE INTERACTION; GENE MUTATION; GERM LINE GENE THERAPY; HUMAN; LUNG ADENOCARCINOMA; NONHUMAN; NOTCH1 ONCOGENE;

EID: 84875798688     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.912     Document Type: Editorial

References (10)

1. Musgrove EA, Caldon CE, Barraclough J, et al. Nature Reviews Cancer. 2011; 11(8):558-572. . Beroukhim R, Mermel CH, Porter D, Wei G, et al. Nature. 2010; 463(7283):899-905.
2. Beroukhim R, Mermel CH, Porter D, Wei G, et al. Nature. 2010; 463(7283):899-905.
3. Choi YJ, Li X, Hydbring P, et al. Cancer Cell. 2012; 22(4):438-451.
4. Sherr CJ and Roberts JM. Genes & Development. 2004; 18(22):2699-2711.
5. Puyol M, Martin A, Dubus P, et al. Cancer Cell. 2010; 18(1):63-73.
6. Sawai CM, Freund J, Oh P, et al. Cancer Cell. 2012; 22(4):452-465.
7. Aster JC, Blacklow SC and Pear WS. The Journal of Pathology. 2011; 223(2):263-274.
8. Goga A, Yang D, Tward AD, Morgan DO et al. Nature Medicine. 2007; 13(7):820-7.
9. Campaner S, Doni M, Hydbring P, Verrecchia A. et al. Nature Cell Biology. 2010; 12(1):54-59.
10. Montagnoli A, Moll J, Colotta F. Clinical Cancer Research. 2010;16(18):4503-8